staurosporine has been researched along with Carcinoma, Endometrioid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gregory-Bass, RC; Liu, D; Matthews, R; Olatinwo, M; Stiles, JK; Thomas, K; Thompson, WE; Tsang, B; Xu, W | 1 |
1 other study(ies) available for staurosporine and Carcinoma, Endometrioid
| Article | Year |
|---|---|
Prohibitin silencing reverses stabilization of mitochondrial integrity and chemoresistance in ovarian cancer cells by increasing their sensitivity to apoptosis.
Topics: Adenoviridae; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Endometrioid; Carcinoma, Papillary; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; G1 Phase; Gene Expression Regulation, Neoplastic; Gene Silencing; Genetic Vectors; Humans; Ki-67 Antigen; Microscopy, Fluorescence; Mitochondria; Ovarian Neoplasms; Ovary; Prohibitins; Recombinant Proteins; Repressor Proteins; Resting Phase, Cell Cycle; RNA, Small Interfering; Staurosporine; Up-Regulation | 2008 |